Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has ...

GitHub is adopting AI-based scanning for its Code Security tool to expand vulnerability detections beyond the CodeQL static analysis and cover more languages and frameworks. The developer ...

A mysterious brain scanner showed up, and the experiment got reckless fast. Instead of typing code, an AI agent was given direct access to raw brain wave data at 256Hz — no filters, no safeguards.

FORM OF A VERY SPECIAL APP. IF I TOUCH THIS AND THIS, I DON’T FEEL ANYTHING ON THIS SIDE AT ALL. SO THERE’S NO SENSATION. SANDHYA JEJURIKAR HAS NO FEELING ON THE LEFT SIDE OF HER FACE AND NO HEARING ...

Mark Kashef examines how integrating Obsidian, a markdown-based note-taking application, with Claude Code, an AI-driven automation system, can streamline information management. Obsidian’s graph ...

Researchers say they’ve discovered a supply-chain attack flooding repositories with malicious packages that contain invisible code, a technique that’s flummoxing traditional defenses designed to ...

Computer engineers and programmers have long relied on reverse engineering as a way to copy the functionality of a computer program without copying that program’s copyright-protected code directly.

PCWorld reports that Anthropic’s Claude Code AI assistant now features voice mode, allowing developers to control the coding tool through verbal commands. Currently rolling out to 5% of users with ...

A new study finds that certain patterns of AI use are driving cognitive fatigue, while others can help reduce burnout. by Julie Bedard, Matthew Kropp, Megan Hsu, Olivia T. Karaman, Jason Hawes and ...

Though it may be what your mind runs to when you experience a weird neurological symptom, brain tumors are incredibly rare, affecting less than 1% of Americans. Knowing the possible symptoms of a ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...